Literature DB >> 22713529

Naive pooled-data approach for pharmacokinetic studies in pediatrics with a very small sample size.

Iftekhar Mahmood1.   

Abstract

The objective of this study was to evaluate if the pharmacokinetic (PK) parameters (clearance, volumes of distribution, and half-life) from 1 blood sample per subject using naive pooled data (NPD) analysis can be obtained with reasonable accuracy with a very small sample size (n = 5). For this study, 7 drugs were selected from the literature. The PKs of these 7 drugs were studied in pediatrics, and plasma concentrations versus time data for individual subjects from extensive blood sampling were available. For this analysis, only 5 subjects were chosen, and each subject gave 1 blood sample. The estimated PK parameters from NPD analysis were compared with the mean PK parameters obtained from extensive sampling. The result of the study indicated that a fairly accurate estimate of PK parameters can be obtained with 1 blood sample each from a minimum of 5 subjects using NPD analysis. The NPD analysis with sparse-sampling scheme can be useful for PK studies in neonates and very young children, where sample size is small.

Entities:  

Mesh:

Year:  2014        PMID: 22713529     DOI: 10.1097/MJT.0b013e31824ddee3

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  8 in total

1.  Quantitative SPECT imaging and biodistribution point to molecular weight independent tumor uptake for some long-circulating polymer nanocarriers.

Authors:  V Schmitt; C Rodríguez-Rodríguez; J L Hamilton; R A Shenoi; P Schaffer; V Sossi; J N Kizhakkedathu; K Saatchi; U O Häfeli
Journal:  RSC Adv       Date:  2018-02-01       Impact factor: 4.036

2.  Comparative Cerebroprotective Potential of d- and l-Carnosine Following Ischemic Stroke in Mice.

Authors:  Saurabh Jain; Eun-Sun Kim; Donghyun Kim; David Burrows; Milena De Felice; Minyeong Kim; Seung-Hoon Baek; Ali Ali; Jessica Redgrave; Thorsten R Doeppner; Iain Gardner; Ok-Nam Bae; Arshad Majid
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

3.  Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis.

Authors:  Laurens F M Verscheijden; Jan B Koenderink; Saskia N de Wildt; Frans G M Russel
Journal:  PLoS Comput Biol       Date:  2019-06-13       Impact factor: 4.475

4.  Pharmacokinetic-Pharmacodynamic Modeling of Tumor Targeted Drug Delivery Using Nano-Engineered Mesenchymal Stem Cells.

Authors:  Shen Cheng; Susheel Kumar Nethi; Mahmoud Al-Kofahi; Swayam Prabha
Journal:  Pharmaceutics       Date:  2021-01-12       Impact factor: 6.321

5.  In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters.

Authors:  Sawittree Sahakijpijarn; Chaeho Moon; Zachary N Warnken; Esther Y Maier; Jennie E DeVore; Dale J Christensen; John J Koleng; Robert O Williams
Journal:  Int J Pharm X       Date:  2021-02-27

6.  Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis.

Authors:  Thomas Pouplin; Nguyen Duc Bang; Pham Van Toi; Pham Nguyen Phuong; Nguyen Huy Dung; Tran Ngoc Duong; Maxine Caws; Guy E Thwaites; Joel Tarning; Jeremy N Day
Journal:  BMC Infect Dis       Date:  2016-04-02       Impact factor: 3.090

7.  Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya.

Authors:  Michael Green; Kephas Otieno; Abraham Katana; Laurence Slutsker; Simon Kariuki; Peter Ouma; Raquel González; Clara Menendez; Feiko ter Kuile; Meghna Desai
Journal:  Malar J       Date:  2016-01-05       Impact factor: 2.979

8.  Pharmacokinetics of Oral Prednisone at Various Doses in Dogs: Preliminary Findings Using a Naïve Pooled-Data Approach.

Authors:  Lionel Sebbag; Jonathan P Mochel
Journal:  Front Vet Sci       Date:  2020-10-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.